135207-08-8 Usage
Uses
Ethyl 2-cyclopropylthiazole-4-carboxylate, 97% is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals for its unique structural features and reactivity.
Used in Pharmaceutical Industry:
Ethyl 2-cyclopropylthiazole-4-carboxylate, 97% is used as a building block for the development of new drugs, particularly in the synthesis of novel therapeutic agents targeting specific biological pathways or receptors.
Used in Agrochemical Industry:
Ethyl 2-cyclopropylthiazole-4-carboxylate, 97% is used as a precursor in the production of innovative agrochemicals, such as pesticides and herbicides, to improve crop protection and yield.
Used in Organic Synthesis:
Ethyl 2-cyclopropylthiazole-4-carboxylate, 97% is used as a versatile reagent in organic synthesis for the preparation of various organic compounds, including heterocycles, natural products, and specialty chemicals, due to its unique functional groups and reactivity.
Used in Biochemical Research:
Ethyl 2-cyclopropylthiazole-4-carboxylate, 97% is used as a probe or tool compound in biochemical research to study enzyme mechanisms, protein interactions, and other biological processes, taking advantage of its specific structural features and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 135207-08-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,2,0 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 135207-08:
(8*1)+(7*3)+(6*5)+(5*2)+(4*0)+(3*7)+(2*0)+(1*8)=98
98 % 10 = 8
So 135207-08-8 is a valid CAS Registry Number.
135207-08-8Relevant academic research and scientific papers
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
-
Page/Page column 66, (2020/10/09)
The present invention discloses compounds of Formula (I), or pharmaceuticall acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising th
